<DOC>
	<DOCNO>NCT00679653</DOCNO>
	<brief_summary>To study effect sibutramine treatment weight reduction blood pressure improvement three group antihypertensive therapy whose blood pressure adequately control antihypertensive combination treatment .</brief_summary>
	<brief_title>Blood Pressure Weight Trajectory Dual Antihypertensive Combination Plus Sibutramine Versus Placebo Obese Hypertensives</brief_title>
	<detailed_description />
	<mesh_term>Trandolapril</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Felodipine</mesh_term>
	<mesh_term>Verapamil</mesh_term>
	<mesh_term>Sibutramine</mesh_term>
	<criteria>Treated essential hypertension . Obesity : BMI 2735 kg/m2 Secondary hypertension . Stage 3 hypertension . Secondary obesity ; BMI &gt; 35kg/m2 . CAD ; MI within past 6 month ; NYHA stage 3 4 heart failure ; tachyarrhythmia/atrial fibrillation ; myocarditis . Kidney failure . Liver failure . Hyperthyroidism . Unstable DM . Carcinoma . Severe chronic infectious disease . Alcohol drug abuse . Pregnancy . Epilepsy . Psychosis treatment antidepressant major tranquilizer</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>